Dr. Daniel J Resop, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 225 Memorial Dr, Berlin, WI 54923 Phone: 920-361-5538 Fax: 920-361-5499 |
News Archive
A shorter genome comprising only a part of the SARS-CoV-2's RNA genome competes with the normal virus for growth and can potentially prevent viral replication.
ImmunoGen, Inc., a biotechnology company that develops antibody-based targeted anticancer products, today announced that Genentech, a member of the Roche Group, today announced its receipt of a Refuse to File (RTF) letter from the US Food and Drug Administration (FDA) for the accelerated approval of the Biologic License Application (BLA) for trastuzumab-DM1, or T-DM1, submitted in July 2010.
Today marks generics manufacturer Zentiva's first day as an independent organization, following completion of the company's previously announced divestment from Sanofi.
Parents/carers of children aged 4-10 years of age reported that over a one-month period in lockdown, they saw increases in their child's emotional difficulties, such as feeling unhappy, worried, being clingy and experiencing physical symptoms associated with worry, according to early results from the Co-SPACE study, asking parents and carers about their children's mental health through the COVID-19 crisis.
A national, phase II clinical trial examining the effects of resveratrol on individuals with mild to moderate dementia due to Alzheimer's disease has begun as more than two dozen academic institutions recruit volunteers in the coming months. R. Scott Turner, M.D., Ph.D., director of Georgetown University Medical Center's Memory Disorders Program, is the lead investigator for the national study.
› Verified 9 days ago